The new born AASraw gained more investment and attracted more top genius guys in the biochemical industry. There are more advantaged equipment and instruments to be being adopted for analyzing, testing, Synthesis, etc., for example, DSC, GV, HPLC, UV, RV, etc. Till now, there are more than 20 key technology engineers. The fixed assets is more than USD30 million. Beside the long term stable cooperation projects, the yearly scheduled new projects will be 5-8 and the newly adopted technology patent will be 1-2. There are more than 100 kinds of goods for bulk production. And, more than 80 of them are owned and can be produced directly, and more than 20 of them are Synthetic Product Technology. These goods are for more than 30 famous pharmacy companies around the world.